Conscious AI: marketing hype versus patient safety

A philosopher from the University of Cambridge, Dr. Tom McClelland, argues that the discussion around AI consciousness is often speculative and potentially misleading through marketing. He suggests that we lack reliable methods to determine if AI is conscious and that this situation is unlikely to change soon. More critically, he points out that consciousness is not the decisive factor for ethical considerations; sentience — an AI’s capacity to feel good or bad — is what truly matters.

The idea that AI might be conscious is a powerful narrative, frequently used to promote new products or research, but it can obscure more pressing, real-world ethical dilemmas. For medical applications, this distinction is critical. If patients are led to believe an AI possesses understanding or emotions, they may over-rely on its diagnostic capabilities or therapeutic recommendations, potentially delaying human medical intervention. Studies on human-AI interaction in healthcare, such as a 2023 review in the journal *AI in Medicine*, highlight how perceived AI capabilities significantly influence patient trust and treatment adherence.

In wellness and health tech, the narrative of a 'conscious' or 'empathetic' AI could encourage users to develop an emotionally dependent relationship with a tool that merely processes data. This might impact mental health support where the nuances of human experience and connection are paramount. The risk is that if AI is presented as more capable than it is, it could influence diagnoses or treatment plans based on a misapprehension of its true abilities — a risk Dr. McClelland terms 'real harm' that can arise from misplaced belief in machine minds.

As AI integrates further into personal wellness and healthcare, maintain a critical perspective. Understand that sophisticated algorithms do not equate to consciousness or sentience. Always prioritize verified medical information and human clinical oversight.